Dr. Vishakha Panicker is a Board-Certified Medical Oncologist with a MD in Internal medicine and Doctorate of National Board (DrNB) in Medical Oncology, completed with strong academic distinction from the prestigious Tata Medical Centre, Kolkata.
Her clinical practice is rooted in evidence-based, multidisciplinary, and patient-centred cancer care, with special interest in solid tumours and precision medicine.
She is an active participant in national and international oncology forums, contributing academically.
She is a member of the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), committed to advancing global standards of care.
Recipient of the ESMO Asia Congress Travel Grant 2024, awarded by the Indian Society of Medical and Pediatric Oncology (ISMPO) in recognition of professional contribution.
Above all, she strives to ensure that every patient receives compassionate, ethical, and personalized treatment, with the assurance that they are in safe and dedicated hands.
As a medical oncologist, Dr. Vishakha offers extensive expertise in the management of both solid and haematological malignancies, with a strong focus on precision medicine.
She is highly proficient in administering a wide range of systemic therapies, including chemotherapy, targeted therapies, and immunotherapies.
Her approach integrates advanced clinical knowledge with the latest evidence-based practices to design individualized treatment plans.
She takes a keen interest in tailoring and personalizing cancer treatment to meet each patient’s unique clinical and emotional needs.
She also emphasizes the importance of palliative care, focusing on symptom management, quality of life, and supportive care throughout all stages of illness
Through multidisciplinary collaboration, clear communication, and compassionate support, she strives to deliver holistic care that optimizes outcomes and enhances quality of life for her patients
- DrNB Medical Oncologist – Tata Medical Centre, Kolkata
- MD Medicine – Kasturba Medical College, Mangalore
- MBBS – Kasturba Medical College, Mangalore
Solid organ malignancies, Haematological malignancies, Precision medicine , Target therapy, Immunotherapy
- Panicker V, et al. Experience with triplet therapy in de novo metastatic hormone sensitive prostate cancer: Single center from India. Annals of Oncology, Volume 35, S1542.
- Joseph N, Joseph N, Panicker V, Nelliyanil M, Jindal A, Viveki R. Assessment and Determinants of Emotional Intelligence and Perceived Stress Among Students of a Medical College in South India. Indian Journal of Public Health, 59(4):310–313, Oct–Dec 2015. DOI: 10.4103/0019-557X.169666
POSTER PRESENTATIONS
- Classical seminoma in elderly patients — Experience from a single centre in India — 5th Int. Congress of Asian Oncology Society & Korean Cancer Association, Seoul, 2025
- Experience with triplet therapy in de novo metastatic hormone sensitive prostate cancer — ESMO Asia, 2024
- Longevity Against the Odds — A remarkable case of treatment response in lung cancer (Case report) — Lung Onconomics, 2023, New Delhi
- Low-grade serous ovarian carcinoma — Clinico-pathologic characteristics, treatment patterns and outcome — 3rd Indian Cancer Congress, 2023, Mumbai
- Indian Society of Medical and Pediatric Oncology (ISMPO)
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
Conferences and training
- ISMPO Lung Preceptorship — March 2025
- 5th Int. Congress of Asian Oncology Society & 51st Annual Meeting of Korean Cancer Association — Seoul, South Korea (2025)
- ESMO Asia — 2024, Singapore
- 3rd Indian Cancer Congress — 2023, Mumbai
- Lung Onconomics — 2023, New Delhi
- FERCICON — 2018
- MedisafeCon — Mangalore, 2018
- Manipal McGill Centre for Infectious Disease International Conference — 2018, Mangalore
- International Conference on Health Care in Elderly — 2019, Mangalore
- E-Conference, Association of Physicians of India, Dakshin Kannada — 2020
